熱門資訊> 正文
NanoViricides GAAP每股收益为-0.16美元
2024-05-15 19:18
- NanoViricides press release (NYSE:NNVC): Q1 GAAP EPS of -$0.16.
- As of March 31, 2024, we had cash and cash equivalent current assets balance of approximately $3.51 Million. Additional agreements have resulted in a further approximately $2.5 Million available cash, that would be equivalent to a total of approximately $6 Million cash available to the Company with no further costs.
More on NanoViricides
- Seeking Alpha’s Quant Rating on NanoViricides
- Historical earnings data for NanoViricides
- Financial information for NanoViricides
推薦文章
風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。
